Sarunas Legeckas on afounder
The useful signal here is where the capital goes: toward clinical proof. In biotech, financing only matters if it gets the science closer to an answer.
The useful signal here is where the capital goes: toward clinical proof. In biotech, financing only matters if it gets the science closer to an answer.